Tools
Stock profile

MOLINA HEALTHCARE, INC. (MOH)

MOH · Latest close $206.56 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$206.56
As of Nov 18, 2026
Tracked funds holding
4 of 149
2026 Q2 13F filings
Opened / added
1 / 0
vs previous quarter
Trimmed / exited
3
vs previous quarter

MOLINA HEALTHCARE, INC. (MOH) is held by 4 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund opening new positions and 3 funds trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $2.3M sold). Latest close $206.56 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 16, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-2.3M
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Investment Management Associates · Baupost Group · Oakmark Funds — 4 tracked funds hold MOH. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 4 sales ($2.3M). Insider trading

Often held alongside

Elevance Health, Inc. (ELV) · Cigna Group (CI) · HUMANA INC (HUM) · CENTENE CORP (CNC) · Oscar Health, Inc. (OSCR) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Investment Management Associates10.80%230,258TRIMMED (-1.2%) Q3 filed Oct 29
Baupost Group2.68%633,609HELD Q3 filed Nov 13
Oakmark Funds0.29%957,500TRIMMED (-2.1%) Q3 filed Nov 16
Samlyn Capital0.27%71,275NEW Q3 filed Nov 16
Maverick Capital——EXITED

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: -4.9% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

353.24113.432024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding601 of 8,857 filers
Long-only filers among them598
Change vs 2026 Q1+85 net · 567 entered · 482 exited
Shares reported, all filers55,829,629
Reported value, all filers$12.3B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryHospital & Medical Service Plans (SIC 6324)
Revenue · FY2025$45.4B
Net income · FY2025$472.0M
Total assets · FY2025$15.6B
Shares outstanding52,200,000
Market cap (at latest close)$10.8B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Oct 16, 2026.

Short interest

Shares short · Oct 15, 20262,993,244
Share of shares outstanding5.73%
Days to cover3.68

Shares short at recent settlements — Jul 31, 2026: 2.9M · Aug 14, 2026: 2.8M · Aug 31, 2026: 3.1M · Sep 15, 2026: 3.2M · Sep 30, 2026: 2.9M · Oct 15, 2026: 3.0M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Oct 16, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 2026200
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 2026<0.1%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 200.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Oct 16, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 4 sales by 4 insiders ($2.3M).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Nov 16, 2026ORLANDO STEVEN JSell702$227.33$159.6KSEC filing
Nov 13, 2026WOLF DALE BSell1,600$206.12$329.8KSEC filing
Nov 10, 2026Schapiro Richard MSell782$203.94$159.5KSEC filing
Nov 10, 2026Barlow Jeff D.Chief Legal OfficerSell8,000$203.07$1.6MSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
May 14, 2026MAURICE HEBERTOfficer600$114.9KMay 14, 2026SEC filing
May 11, 2026JEFF D BARLOWOfficer17,811$3.3MMay 11, 2026SEC filing
Mar 12, 2026ROMNEY RONNADirector506$74.2KMar 11, 2026SEC filing
Nov 24, 2025Schapiro Richard MDirector357$50.5KNov 24, 2025SEC filing
Aug 4, 2025ROMNEY RONNADirector700$110.6KAug 4, 2025SEC filing
May 21, 2025THE DALE B. WOLF REVOCABLE TRUSTDirector1,500$484.3KMay 21, 2025SEC filing
May 2, 2025ORLANDO STEVEN JDirector1,000$315.0KMay 5, 2025SEC filing
Apr 30, 2025Joseph M. ZubretskyPresident / CEO / Director87,500$28.0MApr 30, 2025SEC filing
Apr 29, 2025Schapiro Richard MDirector669$214.2KApr 29, 2025SEC filing
Mar 3, 2025ORLANDO STEVEN JDirector1,000$301.0KMar 3, 2025SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Sep 3, 2026Giovanni Agnelli B.V.SC 13G2,718,3485.2%Aug 28, 2026SEC filing
Aug 13, 2026AQR Capital Management, LLCSC 13G/A3,560,6016.8%Jun 30, 2026SEC filing
Aug 12, 2026Capital World InvestorsSC 13G/A2,565,7134.9%Jun 30, 2026SEC filing
Aug 6, 2026FMR LLCSC 13G/A1,871,290.183.6%Jun 30, 2026SEC filing
May 14, 2026AQR Capital Management, LLCSC 13G2,863,3935.5%Mar 31, 2026SEC filing
Apr 30, 2026Vanguard Capital ManagementSC 13G2,704,9515.2%Mar 31, 2026SEC filing
Apr 29, 2026Vanguard Portfolio ManagementSC 13G2,801,1215.4%Mar 31, 2026SEC filing
Apr 7, 2026BlackRock, Inc.SC 13G/A6,116,37111.7%Mar 31, 2026SEC filing
Mar 27, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Feb 17, 2026T. Rowe Price Associates, Inc.SC 13G/A994,2601.9%Dec 31, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Hospital & Medical Service Plans (SIC 6324). Standing committees with jurisdiction over this industry: House Committee on Financial Services, Senate Committee on Banking, Housing, and Urban Affairs.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 239 Lobbying Disclosure Act filings named this company as client, 2001–2026; most common issues: Medicare/Medicaid (207), Health Issues (46), Taxation/Internal Revenue Code (6).

Federal contracts: no obligated amounts found for this ticker (USASpending, fiscal years 2021–2026).

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Financial Screens

· Growth — Revenue up every year for 5 straight years

· Graham — Sound finances and a long run of profits

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

Key figures

· Growth — Latest revenue: $45.4B · 5-yr revenue CAGR: 18.5% · Straight growth years: 6

· Graham — Current ratio: 1.69 · Straight profitable years: 8 · Debt ratio: 2.83 · Latest net income: $472.0M

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Politician BEST — appeared in 1 of the last 20 quarterly lists; latest 2023 Q2, ranked #24 of 50.

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together10.0%-1.9%-0.5%-1.4%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold MOH — ranked by lift, the co-holding pattern described in Methodology: Elevance Health, Inc. (ELV) · Cigna Group (CI) · HUMANA INC (HUM) · CENTENE CORP (CNC) · Oscar Health, Inc. (OSCR) · TRUPANION, INC. (TRUP) · PROGRESSIVE CORP/OH/ (PGR) · Chubb Ltd (CB).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Nov 6, 20267.01 Regulation FD DisclosureSEC filing
Oct 21, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Jul 22, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

Elevance Health, Inc. (ELV) · Track Record: how the signals scored · Practice timing on MOH

One email a week: the week’s new filings and research. Subscribe free

← MOG.B  ·  MORN →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.